Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Axonal transport of adeno-associated viral vectors is serotype-dependent

Abstract

We have previously shown that adeno-associated virus type 2 (AAV2) undergoes anterograde axonal transport in rat and non-human primate brain. We screened other AAV serotypes for axonal transport and found that AAV6 is transported almost exclusively in a retrograde direction and, in the same way as AAV2, it is also neuron-specific in rat brain. Our findings show that axonal transport of AAV is serotype dependent and this has implications for gene therapy of neurological diseases such as Huntington's disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Ciesielska A, Mittermeyer G, Hadaczek P, Kells AP, Forsayeth J, Bankiewicz KS . Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol Ther 2011; 19: 922–927.

    Article  CAS  Google Scholar 

  2. Kells AP, Hadaczek P, Yin D, Bringas J, Varenika V, Forsayeth J et al. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci USA 2009; 106: 2407–2411.

    Article  CAS  Google Scholar 

  3. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH . Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003; 301: 839–842.

    Article  CAS  Google Scholar 

  4. Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P et al. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther 2009; 20: 225–237.

    Article  CAS  Google Scholar 

  5. Daadi MM, Pivirotto P, Bringas J, Cunningham J, Forsayeth J, Eberling J et al. Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys. Neuroreport 2006; 17: 201–204.

    Article  CAS  Google Scholar 

  6. Kha HT, Finkelstein DI, Tomas D, Drago J, Pow DV, Horne MK . Projections from the substantia nigra pars reticulata to the motor thalamus of the rat: single axon reconstructions and immunohistochemical study. J Comp Neurol 2001; 440: 20–30.

    Article  CAS  Google Scholar 

  7. Thomas CE, Storm TA, Huang Z, Kay MA . Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 3110–3122.

    Article  CAS  Google Scholar 

  8. Frampton Jr AR, Goins WF, Nakano K, Burton EA, Glorioso JC . HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Therapy 2005; 12: 891–901.

    Article  CAS  Google Scholar 

  9. McGraw HM, Awasthi S, Wojcechowskyj JA, Friedman HM . Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. J Virol 2009; 83: 8315–8326.

    Article  CAS  Google Scholar 

  10. Kuo H, Ingram DK, Crystal RG, Mastrangeli A . Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies. Brain Res 1995; 705: 31–38.

    Article  CAS  Google Scholar 

  11. Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL . Transport and egress of herpes simplex virus in neurons. Rev Med Virol 2008; 18: 35–51.

    Article  Google Scholar 

  12. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381–6388.

    Article  CAS  Google Scholar 

  13. Burger C, Gorbatyuk O, Velardo M, Peden C, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2 and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302–317.

    Article  CAS  Google Scholar 

  14. Choi VW, McCarty DM, Samulski RJ . AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 2005; 5: 299–310.

    Article  CAS  Google Scholar 

  15. Fitzsimons HL, Bland RJ, During MJ . Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002; 28: 227–236.

    Article  CAS  Google Scholar 

  16. Green AP, Huang JJ, Scott MO, Kierstead TD, Beaupre I, Gao GP et al. A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther 2002; 13: 1921–1934.

    Article  CAS  Google Scholar 

  17. Klein RL, Dayton RD, Tatom JB, Henderson KM, Henning PP . AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther 2008; 16: 89–96.

    Article  CAS  Google Scholar 

  18. Berardelli A, Noth J, Thompson PD, Bollen EL, Curra A, Deuschl G et al. Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 1999; 14: 398–403.

    Article  CAS  Google Scholar 

  19. Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS et al. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther 2011; 19: 1048–1057.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH grant R01NS073940 to KSB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K S Bankiewicz.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salegio, E., Samaranch, L., Kells, A. et al. Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther 20, 348–352 (2013). https://doi.org/10.1038/gt.2012.27

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2012.27

Keywords

This article is cited by

Search

Quick links